Phase II trial of carboplatin (C) and bevacizumab (BEV) in patients (pts) with breast cancer brain metastases (BCBM).

被引：1
|
作者：
Lin, Nancy U.
Gelman, Rebecca Sue
Younger, W. Jerry
Sohl, Jessica
Freedman, Rachel A.
Sorensen, A. Gregory
Bullitt, Elizabeth
Harris, Gordon J.
Morganstern, Daniel
Schneider, Bryan P.
Krop, Ian E.
Winer, Eric P.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Siemens Healthcare North Amer, Malvern, PA USA
[4] Univ N Carolina, Chapel Hill, NC USA
[5] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
513
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II trial of carboplatin, abraxane, and bevacizumab in NSCLC
    Heist, R. S.
    Duda, G. D.
    Sahani, D.
    Ancukiewicz, M.
    Fidias, P.
    Sequist, L. V.
    Shaw, A. T.
    Temel, J. S.
    Lennes, I. T.
    Neal, J. W.
    Pennell, N. A.
    Lynch, T. J.
    Engelman, J. A.
    Jain, R. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [22] Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases (BCBM)
    Kabraji, Sheheryar
    Ni, Jing
    Sammons, Sarah
    Van Swearingen, Amanda E. D.
    Wang, Yanzhi
    Pereslete, Alyssa M.
    Hsu, Liangge
    Lascola, Chris
    Moore, Heather
    Hughes, Melissa
    Raghavendra, Akshara S.
    Gule-Monroe, Maria
    Murthy, Rashmi K.
    Winer, Eric P.
    Anders, Carey K.
    Zhao, Jean J.
    Lin, Nancy U.
    CANCER RESEARCH, 2022, 82 (04)
  • [23] PHASE II TRIAL OF PACLITAXEL, CARBOPLATIN AND BEVACIZUMAB FOR RECURRENT OR PERSISTENT CERVICAL CANCER
    Suzuki, K.
    Nagao, S.
    Kaneda, M.
    Sibutani, T.
    Yamamoto, K.
    Jimi, T.
    Yano, H.
    Kitai, M.
    Shiozaki, T.
    Matsuoka, K.
    Sudo, T.
    Yamaguchi, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 411 - 411
  • [24] Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer
    Suzuki, Kazuhiro
    Nagao, Shoji
    Shibutani, Takashi
    Yamamoto, Kasumi
    Jimi, Tomoatsu
    Yano, Hiroko
    Kitai, Miho
    Shiozaki, Takaya
    Matsuoka, Kazuko
    Yamaguchi, Satoshi
    GYNECOLOGIC ONCOLOGY, 2019, 154 (03) : 554 - 557
  • [25] A Phase II trial of doxil, carboplatin and bevacizumab in metastatic triple negative breast cancer and molecular correlates of response
    Hirshfield, Kim M.
    Lu, Shou-En
    Wong, Serena
    Tan, Antoinette
    Kirstein, Laurie
    Kearney, Thomas
    Shih, Weichung
    Ganesan, Shridar
    Toppmeyer, Deborah L.
    CANCER RESEARCH, 2015, 75
  • [26] A phase II trial of docetaxel plus carboplatin plus bevacizumab as neoadjuvant therapy for triple negative breast cancer
    Chacon Lopez-Muniz, J. I.
    Cardenas, J. D.
    Santos Rodriguez, A. K.
    Esteban Esteban, M. C.
    Munoz Platon, E.
    Rubio Salvador, A. R.
    Alonso Soler, S. E.
    Fernandez Franco, L.
    San Juan del Moral, A.
    Burgueno Lorenzo, I.
    Trujillo Alba, B. L.
    Martinez Moreno, E.
    Moya Gomez, P.
    Cruz Mora, M. A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S283 - S283
  • [27] Phase II trial of gemcitabine, carboplatin, and bevacizumab in chemotherapy-naive patients (Pts) with advanced/metastatic urothelial carcinoma (UC)
    Balar, A. V.
    Milowsky, M. I.
    Apolo, A. B.
    Ostrovnaya, I.
    Iasonos, A.
    Trout, A.
    Regazzi, A. M.
    Garcia-Grossman, I. R.
    Gallagher, D. J.
    Bajorin, D. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [28] Neoadjuvant phase II trial with carboplatin and eribulin in triple negative breast cancer patients
    Giordano, S. B.
    Jeruss, J. S.
    Bethke, K. P.
    Hansen, N. M.
    Khan, S.
    Von Roenn, J.
    Rosen, S.
    Gradishar, W. L.
    Siziopikou, K. P.
    Meservey, C.
    Kaklamani, V.
    CANCER RESEARCH, 2013, 73
  • [29] Phase II trial of pembrolizumab in patients with brain metastases
    Brastianos, Priscilla Kaliopi
    Kim, Albert Eusik
    Giobbie-Hurder, Anita
    Lee, Eudocia Quant
    Lin, Nancy U.
    Overmoyer, Beth
    Wen, Patrick Y.
    Nayak, Lakshmi
    Cohen, Justine Vanessa
    Dietrich, Jorg
    Heist, Rebecca Suk
    Krop, Ian E.
    Lawrence, Donald P.
    Mayer, Erica L.
    Winer, Eric P.
    Shih, Helen Alice
    Oh, Kevin S.
    Cahill, Daniel P.
    Gerstner, Elizabeth R.
    Sullivan, Ryan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients
    Ramaswamy, Bhuvaneswari
    Elias, Anthony D.
    Kelbick, Nicole T.
    Dodley, Angela
    Morrow, Mark
    Hauger, Marsha
    Allen, Joan
    Rhoades, Chris
    Kendra, Kari
    Chen, Helen X.
    Eckhardt, S. Gail
    Shapiro, Charles L.
    CLINICAL CANCER RESEARCH, 2006, 12 (10) : 3124 - 3129
12345